I've read your past posts...you've provided tremendous insight into what now appears as a glaringly obvious massive opportunity...Based on your extensive knowledge of Bucillamine, what do you believe the likelihood the drug will show in having some efficacy in reaching it's primary endpoints? It seems to me the probability is better than most since the PH 3 came so easy and at the guidance of the FDA?
I'm simply trying to gauge risk/reward with the size of the investment...I already have $40k in at .23...thinking of adding more over the next couple weeks, but don't want to be in too deep on something I am not an expert in
Market Data 
Markets 
AI
